Multi-view fusion based on graph convolutional network with attention mechanism for predicting miRNA related to drugs
PLOS Computational Biology · 14.11.2025 · 21 (11) · e1013703
DOI: 10.1371/journal.pcbi.1013703 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Computational Biology, online erschienen am 14.11.2025. Verfasst von Nan Sheng und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Computer Science and Technology, Jilin University, Changchun, China. Hauptthemen laut MEDLINE: MicroRNAs, Computational Biology, Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Postdoctoral Science Foundation, Jilin Provincial Scientific, Technological Development Program.
Abstract (Originalsprache)
MicroRNAs (miRNAs) play crucial roles in cancer progression, invasion, and response to treatment, particularly in regulating anticancer drug resistance and sensitivity. Identifying potential human miRNA-drug associations (MDAs) that manifest as resistance or sensitivity relationships offers valuable insights for cancer treatment and drug development. With the growing availability of biological data, computational methods have emerged as powerful tools to complement experimental approaches. However, limited attention has been paid to computational prediction of MDAs. Furthermore, existing approaches typically rely on known MDA information, overlooking the valuable insights available from multi-source data related to miRNAs and drugs. In this study, we present a multi-view fusion-based graph convolutional network with attention mechanism (MGCNA) to predict miRNA-associated drug resistance/sensitivity. Specifically, MGCNA integrates macro- and micro- level information of miRNAs and drugs to construct multi-view node features from different perspectives. The proposed multi-view graph convolutional network (GCN) encoder obtains miRNA and disease features from different views and learns adaptive importance weights of the embedding using an attention mechanism. Extensive experiments on manually curated benchmark datasets demonstrate that MGCNA outperforms existing baseline methods. Case studies of two common drugs further establish MGCNA’s effectiveness in discovering novel MDAs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Computer Science and Technology, Jilin University, Changchun, China.
- Key Laboratory of Symbolic Computation and Knowledge Engineering of the Ministry of Education, Jilin University, Changchun, China.
Förderung
- China Postdoctoral Science Foundation
- Jilin Provincial Scientific
- Technological Development Program
- Jilin Provincial Scientific and Technological Development Program
Zitieren
APA
Sheng, N., Liu, Y., Gao, L., Wang, L., Huang, L., & Wang, Y. (2025). Multi-view fusion based on graph convolutional network with attention mechanism for predicting miRNA related to drugs. PLOS Computational Biology, 21(11), e1013703. https://doi.org/10.1371/journal.pcbi.1013703
Vancouver
Sheng N, Liu Y, Gao L, Wang L, Huang L, Wang Y. Multi-view fusion based on graph convolutional network with attention mechanism for predicting miRNA related to drugs. PLOS Computational Biology. 2025;21(11):e1013703. doi:10.1371/journal.pcbi.1013703
BibTeX
@article{Sheng2025,
author = {Sheng, Nan and Liu, Yunzhi and Gao, Ling and Wang, Lei and Huang, Lan and Wang, Yan},
title = {Multi-view fusion based on graph convolutional network with attention mechanism for predicting miRNA related to drugs},
journal = {PLOS Computational Biology},
year = {2025},
volume = {21},
number = {11},
pages = {e1013703},
doi = {10.1371/journal.pcbi.1013703}
}
EUVIMED